The use of konjac glucomannan hydrolysates to recover healthy microbiota in infected vaginas treated with an antifungal agent

Richard Tester, Farage H. Al-Ghazzewi, N. Shen, Z. Chen , J. Yang, D. Zhang , M. Tang

Research output: Contribution to journalArticle


The aim of this study was to evaluate how konjac glucomannan hydrolysates (GMH) could support the healthy re-colonisation of vaginal microflora post infections. A total of 26 female patients (12 controls and 14 treatments) aged 18 to 25 suffering from vaginal infection were recruited for this study. Patients were assigned randomly into two groups to receive a standard antifungal treatment or a standard antifungal treatment plus pessary capsules containing 200 mg GMH (twice a week for thirty days). Patients were assessed on day zero, sixteen and thirty of the trial.
Original languageEnglish
Pages (from-to)61-66
Number of pages6
JournalBeneficial Microbes
Issue number1
Publication statusPublished - Mar 2012



  • konjac glucomannan hydrolysates
  • microflora
  • antifungal agents

Cite this